The North America Computer Vision In Healthcare Market would witness market growth of 35.6% CAGR during the forecast period (2023-2030).
Computer vision has ushered in a transformative era for the healthcare industry, revolutionizing how healthcare professionals diagnose, monitor, and treat patients. In recent years, computer vision in healthcare has gained immense momentum and is poised to significantly impact the market. This cutting-edge technology leverages advanced algorithms and artificial intelligence to interpret visual data from a myriad of medical imaging sources, including X-rays, MRIs, CT scans, and even digital pathology slides.
The integration of computer vision in healthcare is not merely a technological innovation; it represents a paradigm shift in the medical field. This transformation is underpinned by the ability of computer vision systems to process, analyze, and extract valuable insights from vast datasets with unprecedented accuracy, efficiency, and speed. As a result, healthcare providers are now better equipped to make more informed clinical decisions, reduce errors, and improve patient outcomes.
Computer vision systems improve the accuracy of medical diagnoses by minimizing false positives, which may lessen the need for unnecessary surgeries and expensive treatments. Computer vision, utilizing sophisticated algorithms trained on large datasets, can spot even subtle signs of a medical disorder that human doctors might miss due to inherent sensory limitations. Computer vision in medical diagnosis can offer remarkably high degrees of accuracy, with developments pointing to the possibility of achieving precision levels close to 100%.
The rising demand for early diagnoses further propels the market’s expansion in the North America region. For instance, the Canadian Cancer Society’s 2022 study estimates that there were roughly 233,900 new instances of cancer identified in Canada that year. Additionally, 641 Canadians received cancer diagnoses daily on average, with future projections indicating an increase in this number. According to the same source, the most common cancers in Canada (aside from non-melanoma skin cancer) are breast, colorectal, lung, and prostate.
Computer vision technology has become instrumental in the early detection and diagnosis of chronic diseases. Chronic diseases often require personalized treatment plans that consider individual patient characteristics and medical history. Computer vision applications can help create patient-specific care plans by analyzing data and images to tailor treatment recommendations, medication dosages, and lifestyle interventions. The growing burden of chronic diseases in North America can be managed in large part by implementing computer vision in healthcare. Therefore, the regional market will expand in the coming years due to the abovementioned factors.
The US market dominated the North America Computer Vision In Healthcare Market, By Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $3,676.6 Million by 2030. The Canada market is exhibiting a CAGR of 38.7% during (2023 - 2030). Additionally, The Mexico market would experience a CAGR of 37.5% during (2023 - 2030).
Based on Application, the market is segmented into Medical Imaging & Diagnostics, Surgeries, Patient Management & Research, and Others. Based on End-use, the market is segmented into Healthcare Providers, Diagnostic Centers, Academic Research Institutes, and Others. Based on Component, the market is segmented into Hardware, Software, and Services. Based on Product Type, the market is segmented into Smart Cameras-based Computer Vision Systems, and PC-based Computer Vision Systems. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include NVIDIA Corporation, Microsoft Corporation, Intel Corporation, IBM Corporation, Google LLC, iCAD Inc., Basler AG, Arterys Inc. (Tempus Labs, Inc.), AiCure, LLC, and Xilinx, Inc. (Advanced Micro Devices, Inc.).
Scope of the Study
Market Segments covered in the Report:
By Application

  • Medical Imaging & Diagnostics
  • Surgeries
  • Patient Management & Research
  • Others


By End-use

  • Healthcare Providers
  • Diagnostic Centers
  • Academic Research Institutes
  • Others


By Component

  • Hardware
  • Software
  • Services


By Product Type

  • Smart Cameras-based Computer Vision Systems
  • PC-based Computer Vision Systems


By Country

  • US
  • Canada
  • Mexico
  • Rest of North America


Companies Profiled

  • NVIDIA Corporation
  • Microsoft Corporation
  • Intel Corporation
  • IBM Corporation
  • Google LLC
  • iCAD Inc.
  • Basler AG
  • Arterys Inc. (Tempus Labs, Inc.)
  • AiCure, LLC
  • Xilinx, Inc. (Advanced Micro Devices, Inc.)


Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free